2023 Q4 Form 10-Q Financial Statement

#000118518523001307 Filed on December 15, 2023

View on sec.gov

Income Statement

Concept 2023 Q4
Revenue $13.58M
YoY Change 51.69%
Cost Of Revenue $9.245M
YoY Change 7.51%
Gross Profit $4.330M
YoY Change 1137.14%
Gross Profit Margin 31.9%
Selling, General & Admin $2.552M
YoY Change 25.47%
% of Gross Profit 58.94%
Research & Development $840.0K
YoY Change 40.23%
% of Gross Profit 19.4%
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $3.392M
YoY Change 28.83%
Operating Profit $938.0K
YoY Change -141.09%
Interest Expense $29.00K
YoY Change 61.11%
% of Operating Profit 3.09%
Other Income/Expense, Net $0.00
YoY Change
Pretax Income $803.0K
YoY Change -134.72%
Income Tax $6.000K
% Of Pretax Income 0.75%
Net Earnings $797.0K
YoY Change -134.44%
Net Earnings / Revenue 5.87%
Basic Earnings Per Share $0.08
Diluted Earnings Per Share $0.08
COMMON SHARES
Basic Shares Outstanding 9.399M shares
Diluted Shares Outstanding 9.399M shares

Balance Sheet

Concept 2023 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $8.708M
YoY Change -55.87%
Cash & Equivalents $8.708M
Short-Term Investments
Other Short-Term Assets $1.669M
YoY Change 27.4%
Inventory $23.07M
Prepaid Expenses
Receivables $3.781M
Other Receivables $0.00
Total Short-Term Assets $49.70M
YoY Change -10.04%
LONG-TERM ASSETS
Property, Plant & Equipment $6.436M
YoY Change -21.01%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $876.0K
YoY Change -2.56%
Total Long-Term Assets $25.03M
YoY Change -10.07%
TOTAL ASSETS
Total Short-Term Assets $49.70M
Total Long-Term Assets $25.03M
Total Assets $74.73M
YoY Change -10.05%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.245M
YoY Change -14.78%
Accrued Expenses $4.049M
YoY Change 21.26%
Deferred Revenue $16.44M
YoY Change -3.19%
Short-Term Debt $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $24.98M
YoY Change -7.06%
LONG-TERM LIABILITIES
Long-Term Debt $0.00
YoY Change
Other Long-Term Liabilities $131.0K
YoY Change 5.65%
Total Long-Term Liabilities $131.0K
YoY Change 5.65%
TOTAL LIABILITIES
Total Short-Term Liabilities $24.98M
Total Long-Term Liabilities $131.0K
Total Liabilities $38.47M
YoY Change -8.7%
SHAREHOLDERS EQUITY
Retained Earnings -$22.78M
YoY Change -10.84%
Common Stock $9.405M
YoY Change 0.76%
Preferred Stock
YoY Change
Treasury Stock (at cost) $3.000K
YoY Change -50.0%
Treasury Stock Shares
Shareholders Equity $36.26M
YoY Change
Total Liabilities & Shareholders Equity $74.73M
YoY Change -10.05%

Cashflow Statement

Concept 2023 Q4
OPERATING ACTIVITIES
Net Income $797.0K
YoY Change -134.44%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$181.0K
YoY Change -105.82%
INVESTING ACTIVITIES
Capital Expenditures $170.0K
YoY Change -164.39%
Acquisitions
YoY Change
Other Investing Activities $0.00
YoY Change -100.0%
Cash From Investing Activities -$170.0K
YoY Change -27.35%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 0.000
YoY Change
NET CHANGE
Cash From Operating Activities -181.0K
Cash From Investing Activities -170.0K
Cash From Financing Activities 0.000
Net Change In Cash -351.0K
YoY Change -112.21%
FREE CASH FLOW
Cash From Operating Activities -$181.0K
Capital Expenditures $170.0K
Free Cash Flow -$351.0K
YoY Change -110.41%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
shares
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2023-10-31
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
1-8061
dei Entity Registrant Name
EntityRegistrantName
FREQUENCY ELECTRONICS, INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
11-1986657
dei Entity Address Address Line1
EntityAddressAddressLine1
55 CHARLES LINDBERGH BLVD.
dei Entity Address City Or Town
EntityAddressCityOrTown
MITCHEL FIELD
dei Entity Address State Or Province
EntityAddressStateOrProvince
NY
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
11553
dei City Area Code
CityAreaCode
516
dei Local Phone Number
LocalPhoneNumber
794-4500
dei Security12b Title
Security12bTitle
Common Stock (par value $1.00 per share)
dei Trading Symbol
TradingSymbol
FEIM
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2023Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
9415417 shares
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
8708000 usd
CY2023Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
12049000 usd
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
111000 usd
CY2023Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
111000 usd
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
3781000 usd
CY2023Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
4622000 usd
CY2023Q4 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
12474000 usd
CY2023Q2 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
10009000 usd
CY2023Q4 us-gaap Inventory Net
InventoryNet
23071000 usd
CY2023Q2 us-gaap Inventory Net
InventoryNet
20526000 usd
CY2023Q4 us-gaap Prepaid Taxes
PrepaidTaxes
30000 usd
CY2023Q2 us-gaap Prepaid Taxes
PrepaidTaxes
30000 usd
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1639000 usd
CY2023Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1071000 usd
CY2023Q4 us-gaap Assets Current
AssetsCurrent
49703000 usd
CY2023Q2 us-gaap Assets Current
AssetsCurrent
48307000 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
6436000 usd
CY2023Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
7093000 usd
CY2023Q4 us-gaap Intangible Assets Net Including Goodwill
IntangibleAssetsNetIncludingGoodwill
617000 usd
CY2023Q2 us-gaap Intangible Assets Net Including Goodwill
IntangibleAssetsNetIncludingGoodwill
617000 usd
CY2023Q4 feim Cash Surrender Value Of Life Insurance And Cash Held In Trust
CashSurrenderValueOfLifeInsuranceAndCashHeldInTrust
10404000 usd
CY2023Q2 feim Cash Surrender Value Of Life Insurance And Cash Held In Trust
CashSurrenderValueOfLifeInsuranceAndCashHeldInTrust
10220000 usd
CY2023Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
876000 usd
CY2023Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
877000 usd
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
6693000 usd
CY2023Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
7382000 usd
CY2023Q4 us-gaap Assets
Assets
74729000 usd
CY2023Q2 us-gaap Assets
Assets
74496000 usd
CY2023Q4 us-gaap Accounts Payable Trade Current
AccountsPayableTradeCurrent
1245000 usd
CY2023Q2 us-gaap Accounts Payable Trade Current
AccountsPayableTradeCurrent
1464000 usd
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
4049000 usd
CY2023Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
3934000 usd
CY2023Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
1481000 usd
CY2023Q2 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
1544000 usd
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1769000 usd
CY2023Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1753000 usd
CY2023Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
16435000 usd
CY2023Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
18586000 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
24979000 usd
CY2023Q2 us-gaap Liabilities Current
LiabilitiesCurrent
27281000 usd
CY2023Q4 us-gaap Deferred Compensation Liability Classified Noncurrent
DeferredCompensationLiabilityClassifiedNoncurrent
8229000 usd
CY2023Q2 us-gaap Deferred Compensation Liability Classified Noncurrent
DeferredCompensationLiabilityClassifiedNoncurrent
8314000 usd
CY2023Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
8000 usd
CY2023Q2 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
8000 usd
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
5126000 usd
CY2023Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
5883000 usd
CY2023Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
131000 usd
CY2023Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
124000 usd
CY2023Q4 us-gaap Liabilities
Liabilities
38473000 usd
CY2023Q2 us-gaap Liabilities
Liabilities
41610000 usd
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
1
CY2023Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
1
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
600000 shares
CY2023Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
600000 shares
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
1
CY2023Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
1
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
20000000 shares
CY2023Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
20000000 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
9404000 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
9403000 shares
CY2023Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
9374000 shares
CY2023Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
9373000 shares
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
9405000 usd
CY2023Q2 us-gaap Common Stock Value
CommonStockValue
9374000 usd
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
49636000 usd
CY2023Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
49136000 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-22782000 usd
CY2023Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-25621000 usd
CY2023Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
1000 shares
CY2023Q2 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
1000 shares
CY2023Q4 us-gaap Treasury Stock Value
TreasuryStockValue
3000 usd
CY2023Q2 us-gaap Treasury Stock Value
TreasuryStockValue
3000 usd
CY2023Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
0 usd
CY2023Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
0 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
36256000 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
32886000 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
74729000 usd
CY2023Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
74496000 usd
CY2023Q4 us-gaap Revenues
Revenues
13575000 usd
CY2022Q4 us-gaap Revenues
Revenues
8949000 usd
us-gaap Revenues
Revenues
25984000 usd
us-gaap Revenues
Revenues
17153000 usd
CY2023Q4 us-gaap Cost Of Revenue
CostOfRevenue
9245000 usd
CY2022Q4 us-gaap Cost Of Revenue
CostOfRevenue
8599000 usd
us-gaap Cost Of Revenue
CostOfRevenue
16786000 usd
us-gaap Cost Of Revenue
CostOfRevenue
16808000 usd
CY2023Q4 us-gaap Gross Profit
GrossProfit
4330000 usd
CY2022Q4 us-gaap Gross Profit
GrossProfit
350000 usd
us-gaap Gross Profit
GrossProfit
9198000 usd
us-gaap Gross Profit
GrossProfit
345000 usd
CY2023Q4 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
2552000 usd
CY2022Q4 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
2034000 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
4853000 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
4026000 usd
CY2023Q4 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
840000 usd
CY2022Q4 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
599000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1347000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1709000 usd
CY2023Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
938000 usd
CY2022Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-2283000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
2998000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-5390000 usd
CY2023Q4 feim Investmentexpense Income
InvestmentexpenseIncome
106000 usd
CY2022Q4 feim Investmentexpense Income
InvestmentexpenseIncome
12000 usd
feim Investmentexpense Income
InvestmentexpenseIncome
86000 usd
feim Investmentexpense Income
InvestmentexpenseIncome
-24000 usd
CY2023Q4 us-gaap Interest Expense
InterestExpense
29000 usd
CY2022Q4 us-gaap Interest Expense
InterestExpense
18000 usd
us-gaap Interest Expense
InterestExpense
60000 usd
us-gaap Interest Expense
InterestExpense
63000 usd
CY2023Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
803000 usd
CY2022Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-2313000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
2852000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-5429000 usd
CY2023Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
6000 usd
CY2022Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
13000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2000 usd
CY2023Q4 us-gaap Net Income Loss
NetIncomeLoss
797000 usd
CY2022Q4 us-gaap Net Income Loss
NetIncomeLoss
-2314000 usd
us-gaap Net Income Loss
NetIncomeLoss
2839000 usd
us-gaap Net Income Loss
NetIncomeLoss
-5431000 usd
CY2023Q4 feim Earnings Per Share Basic And Diluted1
EarningsPerShareBasicAndDiluted1
0.08
CY2022Q4 feim Earnings Per Share Basic And Diluted1
EarningsPerShareBasicAndDiluted1
-0.25
feim Earnings Per Share Basic And Diluted1
EarningsPerShareBasicAndDiluted1
0.3
feim Earnings Per Share Basic And Diluted1
EarningsPerShareBasicAndDiluted1
-0.58
CY2023Q4 feim Weighted Average Number Of Diluted Shares Outstanding1
WeightedAverageNumberOfDilutedSharesOutstanding1
9399000 shares
CY2022Q4 feim Weighted Average Number Of Diluted Shares Outstanding1
WeightedAverageNumberOfDilutedSharesOutstanding1
9326000 shares
feim Weighted Average Number Of Diluted Shares Outstanding1
WeightedAverageNumberOfDilutedSharesOutstanding1
9392000 shares
feim Weighted Average Number Of Diluted Shares Outstanding1
WeightedAverageNumberOfDilutedSharesOutstanding1
9317000 shares
CY2023Q4 us-gaap Net Income Loss
NetIncomeLoss
797000 usd
CY2022Q4 us-gaap Net Income Loss
NetIncomeLoss
-2314000 usd
us-gaap Net Income Loss
NetIncomeLoss
2839000 usd
us-gaap Net Income Loss
NetIncomeLoss
-5431000 usd
CY2023Q4 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Reclassification Adjustments Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax
0 usd
CY2022Q4 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Reclassification Adjustments Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax
-581000 usd
us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Reclassification Adjustments Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax
0 usd
us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Reclassification Adjustments Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax
-552000 usd
CY2023Q4 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax
0 usd
CY2022Q4 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax
-16000 usd
us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax
0 usd
us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax
-1000 usd
CY2023Q4 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
0 usd
CY2022Q4 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-565000 usd
us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
0 usd
us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-551000 usd
CY2023Q4 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
797000 usd
CY2022Q4 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-2879000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
2839000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-5982000 usd
us-gaap Net Income Loss
NetIncomeLoss
2839000 usd
us-gaap Net Income Loss
NetIncomeLoss
-5431000 usd
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-2191000 usd
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-1209000 usd
us-gaap Increase Decrease In Operating Capital
IncreaseDecreaseInOperatingCapital
8011000 usd
us-gaap Increase Decrease In Operating Capital
IncreaseDecreaseInOperatingCapital
-3756000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-2981000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-466000 usd
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
0 usd
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
1137000 usd
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
0 usd
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
1383000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
360000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
729000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-360000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-975000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
0 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
0 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-3341000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-1441000 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
12049000 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
11561000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
8708000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
10120000 usd
us-gaap Interest Paid
InterestPaid
60000 usd
us-gaap Interest Paid
InterestPaid
36000 usd
us-gaap Income Taxes Paid
IncomeTaxesPaid
9000 usd
us-gaap Income Taxes Paid
IncomeTaxesPaid
0 usd
us-gaap Proceeds From Income Tax Refunds
ProceedsFromIncomeTaxRefunds
0 usd
us-gaap Proceeds From Income Tax Refunds
ProceedsFromIncomeTaxRefunds
176000 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
32886000 usd
CY2023Q3 us-gaap Stock Issued During Period Value Employee Benefit Plan
StockIssuedDuringPeriodValueEmployeeBenefitPlan
113000 usd
CY2023Q3 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
128000 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
2042000 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
35169000 usd
CY2023Q4 us-gaap Stock Issued During Period Value Employee Benefit Plan
StockIssuedDuringPeriodValueEmployeeBenefitPlan
88000 usd
CY2023Q4 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
202000 usd
CY2023Q4 us-gaap Net Income Loss
NetIncomeLoss
797000 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
36256000 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
46688000 usd
CY2022Q3 us-gaap Stock Issued During Period Value Employee Benefit Plan
StockIssuedDuringPeriodValueEmployeeBenefitPlan
122000 usd
CY2022Q3 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
-25000 usd
CY2022Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
14000 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-3117000 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
43682000 usd
CY2022Q4 us-gaap Stock Issued During Period Value Employee Benefit Plan
StockIssuedDuringPeriodValueEmployeeBenefitPlan
107000 usd
CY2022Q4 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
29000 usd
CY2022Q4 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-565000 usd
CY2022Q4 us-gaap Net Income Loss
NetIncomeLoss
-2314000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
40939000 usd
CY2023Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
9399052 shares
CY2022Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
9326347 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
9391714 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
9317143 shares
CY2023Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
9399052 shares
CY2022Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
9326347 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
9391714 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
9317143 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
97000 shares
CY2023Q4 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
97000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
243625 shares
CY2022Q4 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
243625 shares
CY2023Q4 us-gaap Contract With Customer Asset Gross
ContractWithCustomerAssetGross
12474000 usd
CY2023Q2 us-gaap Contract With Customer Asset Gross
ContractWithCustomerAssetGross
10009000 usd
CY2023Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
16435000 usd
CY2023Q2 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
18586000 usd
us-gaap Increase Decrease In Contract With Customer Asset
IncreaseDecreaseInContractWithCustomerAsset
2500000 usd
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-2200000 usd
CY2023Q4 us-gaap Loss On Contracts
LossOnContracts
1400000 usd
us-gaap Loss On Contracts
LossOnContracts
1500000 usd
CY2022Q4 us-gaap Loss On Contracts
LossOnContracts
700000 usd
us-gaap Loss On Contracts
LossOnContracts
2000000 usd
CY2023Q4 us-gaap Stock Issued During Period Shares Employee Benefit Plan
StockIssuedDuringPeriodSharesEmployeeBenefitPlan
12885 shares
us-gaap Stock Issued During Period Shares Employee Benefit Plan
StockIssuedDuringPeriodSharesEmployeeBenefitPlan
29898 shares
CY2023Q4 us-gaap Deferred Compensation Arrangement With Individual Compensation Expense
DeferredCompensationArrangementWithIndividualCompensationExpense
109000 usd
us-gaap Deferred Compensation Arrangement With Individual Compensation Expense
DeferredCompensationArrangementWithIndividualCompensationExpense
217000 usd
CY2023Q4 us-gaap Deferred Compensation Arrangement With Individual Distribution Paid
DeferredCompensationArrangementWithIndividualDistributionPaid
175000 usd
us-gaap Deferred Compensation Arrangement With Individual Distribution Paid
DeferredCompensationArrangementWithIndividualDistributionPaid
361000 usd
CY2022Q4 us-gaap Deferred Compensation Arrangement With Individual Compensation Expense
DeferredCompensationArrangementWithIndividualCompensationExpense
109000 usd
us-gaap Deferred Compensation Arrangement With Individual Compensation Expense
DeferredCompensationArrangementWithIndividualCompensationExpense
218000 usd
CY2022Q4 us-gaap Deferred Compensation Arrangement With Individual Distribution Paid
DeferredCompensationArrangementWithIndividualDistributionPaid
159000 usd
us-gaap Deferred Compensation Arrangement With Individual Distribution Paid
DeferredCompensationArrangementWithIndividualDistributionPaid
320000 usd
CY2023Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
14193000 usd
CY2023Q2 us-gaap Inventory Raw Materials
InventoryRawMaterials
12460000 usd
CY2023Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
8336000 usd
CY2023Q2 us-gaap Inventory Work In Process
InventoryWorkInProcess
7547000 usd
CY2023Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
542000 usd
CY2023Q2 us-gaap Inventory Finished Goods
InventoryFinishedGoods
519000 usd
CY2023Q4 us-gaap Inventory Net
InventoryNet
23071000 usd
CY2023Q2 us-gaap Inventory Net
InventoryNet
20526000 usd
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
6693000 usd
CY2023Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
7382000 usd
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1769000 usd
CY2023Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1753000 usd
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
5126000 usd
CY2023Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
5883000 usd
CY2023Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
6895000 usd
CY2023Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
7636000 usd
CY2023Q4 us-gaap Operating Lease Expense
OperatingLeaseExpense
466000 usd
us-gaap Operating Lease Expense
OperatingLeaseExpense
921000 usd
CY2022Q4 us-gaap Operating Lease Expense
OperatingLeaseExpense
481000 usd
us-gaap Operating Lease Expense
OperatingLeaseExpense
962000 usd
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
815000 usd
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
1844000 usd
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
1328000 usd
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
937000 usd
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
1262000 usd
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
1976000 usd
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
8162000 usd
CY2023Q4 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
1267000 usd
CY2023Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
6895000 usd
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1769000 usd
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
5126000 usd
CY2023Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P5Y3M7D
CY2022Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P5Y11M19D
CY2023Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0628 pure
CY2022Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0619 pure
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2 pure
CY2023Q4 feim Number Of Principal Markets
NumberOfPrincipalMarkets
3 pure
CY2023Q4 us-gaap Revenues
Revenues
13575000 usd
CY2022Q4 us-gaap Revenues
Revenues
8949000 usd
us-gaap Revenues
Revenues
25984000 usd
us-gaap Revenues
Revenues
17153000 usd
CY2023Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
938000 usd
CY2022Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-2283000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
2998000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-5390000 usd
CY2023Q4 us-gaap Assets
Assets
74729000 usd
CY2023Q2 us-gaap Assets
Assets
74496000 usd
CY2023Q4 us-gaap Revenues
Revenues
13600000 usd
us-gaap Revenues
Revenues
26000000 usd
CY2022Q4 us-gaap Revenues
Revenues
9000000 usd
us-gaap Revenues
Revenues
17200000 usd
CY2023Q4 us-gaap Revenues
Revenues
13575000 usd
CY2022Q4 us-gaap Revenues
Revenues
8949000 usd
us-gaap Revenues
Revenues
25984000 usd
us-gaap Revenues
Revenues
17153000 usd
CY2023Q4 us-gaap Revenues
Revenues
13575000 usd
CY2022Q4 us-gaap Revenues
Revenues
8949000 usd
us-gaap Revenues
Revenues
25984000 usd
us-gaap Revenues
Revenues
17153000 usd
CY2022Q4 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
31000 usd
CY2023Q4 feim Cost Method Investment Ownership Percentage
CostMethodInvestmentOwnershipPercentage
0.046 pure
CY2023Q4 us-gaap Preferred Stock Value
PreferredStockValue
usd
CY2023Q2 us-gaap Preferred Stock Value
PreferredStockValue
usd
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
shares
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--04-30
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
dei Entity Central Index Key
EntityCentralIndexKey
0000039020

Files In Submission

Name View Source Status
0001185185-23-001307-index-headers.html Edgar Link pending
0001185185-23-001307-index.html Edgar Link pending
0001185185-23-001307.txt Edgar Link pending
0001185185-23-001307-xbrl.zip Edgar Link pending
ex_606493.htm Edgar Link pending
ex_606494.htm Edgar Link pending
ex_606495.htm Edgar Link pending
feim-20231031.xsd Edgar Link pending
Financial_Report.xlsx Edgar Link pending
freqelec20231031_10q.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
feim-20231031_lab.xml Edgar Link unprocessable
feim-20231031_pre.xml Edgar Link unprocessable
feim-20231031_def.xml Edgar Link unprocessable
feim-20231031_cal.xml Edgar Link unprocessable
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
freqelec20231031_10q_htm.xml Edgar Link completed